October 15, 2012 — Cardiac Science has unveiled its Burdick 4250 Holter recorder — a wearable heart monitor half the size and weight of its Holter monitoring system predecessor.

Three-year data from the Zilver PTX randomized controlled trial of paclitaxel-eluting stents for femoropopliteal disease from Cook Medical demonstrate 70.7 percent primary patency in the superficial femoral artery (SFA) at 36 months for patients treated with the paclitaxel-eluting stent.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now